Eli Lilly and Co

Eli Lilly and Company cast itself as a pharmaceutical company that discovers, develops, and manufactures pharmaceutical products. The company came into being in 1876. It was founded by pharmaceutical chemist Eli Lilly who served’ as its president until his death in 1898. Headquartered in Indianapolis, Indiana, the company operates under two segments of Pharmaceutical human products and Animal health.

It develops and offers treatment options for diabetes as well as osteoporosis in men and women. In addition to offering immunology products, Eli Lilly also develops neuroscience products for treating the depressive disorder and neuropathic pain. Its animal health unit develops and offers cattle feed additives as well as leanness and performance enhancers for swine.

The company’s biggest achievements to date include the mass production of the polio vaccine as well a being the first company to develop human insulin using recombinant DNA.

The company boasts of a primary listing on the New York Stock Exchange and is a component of the S&P 100 and S&P 500.

Latest Eli Lilly and Co News

Investing is speculative. When investing your capital is at risk. This site is not intended for use in jurisdictions in which the trading or investments described are prohibited and should only be used by such persons and in such ways as are legally permitted. Your investment may not qualify for investor protection in your country or state of residence, so please conduct your own due diligence. This website is free for you to use but we may receive commission from the companies we feature on this site. Click here for more information.